Clinical Trial Update: Neoadjuvant Immunochemotherapy and Postoperative Adjuvant Immunotherapy for Head and Neck Squamous Cell Carcinoma Invading the Skull Base [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial assessing neoadjuvant chemoimmunotherapy followed by postoperative adjuvant immunotherapy for head and neck squamous cell carcinoma inv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Head and Neck Cancer Squamous Cell Carcinoma, Skull Base--Cancer | Phase 2 | Status: NOT_YET_RECRUITING